evaluable


Also found in: Dictionary.

evaluable

A clinical trials term of art for data or subjects meeting the study’s statistical analysis plan criteria for inclusion in Efficacy/Safety data sets.
References in periodicals archive ?
Patients were divided into two populations: 73 evaluable patients with relapsed and/or refractory multiple myeloma who had not received prior bortezomib (Velcade[R]) treatment, classified as bortezomib-naive patients, and 33 evaluable patients with relapsed and/or refractory disease following bortezomib treatment, classified as bortezomib-treated patients.
Overall cure rates in the clinically evaluable population were 93.
During follow-up, LVEF increased by an average of 3% over baseline in 92 evaluable control patients and by an average of 5.
The ITT group was defined as patients who received at least one dose of study medication and completed at least one study evaluation, while the evaluable population was the subset of 75 patients (n=50 chromium picolinate and 25 placebo), who took at least 80% of the study product with no significant protocol deviations.
Efficacy -- Data on the debridement of wound eschar (removal of burned tissue) were analyzed from seven evaluable patients and data on the time to 90 percent epithelialization (the point at which wounds appear to be healing normally) were analyzed from 12 evaluable patients:
At the time of the data cutoff, 20 patients were evaluable for safety and 11 patients were evaluable for efficacy.
The CRP level continued to gradually drop during subsequent treatment, and after 24 weeks, was at an average of 2 mg/L in 37 evaluable patients.
The study with Onyvax-P targets a total of 48 evaluable patients.
As of the November 1, 2010 cut-off date, a total of 51 patients were enrolled into the ovarian cancer cohort, with 31 evaluable for response, and 41 evaluable for safety.
WASHINGTON -- Once-daily treatment with ertapenem was as safe and effective as a four-times daily regimen with two other antibiotics for treating diabetic patients with moderate to severe foot infections in a controlled study with 445 evaluable patients.
Of the 21 evaluable patients who entered the study at least six months ago, ten (48%) have survived more than six months.